Findings

What do systematic reviews say?

6 questions · 6 findings · 1 reviews · Urology

Sort:Best matchNewest Highest certainty Download CSV

No studies found 3 · 50%GRADE not reported 0 · 0%Very low 0 · 0%Low 3 · 50%Moderate 0 · 0%High 0 · 0%

Botulinum toxin type A vs placebo

Prostatitis symptoms Subgroup: Intraprostatic injection, participants age > 50 years old, basal NIH‐CPSI score > 30 · participants with chronic prostatitis/chronic pelvic pain syndrome

1 finding from 1 review

Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 60 participants
Low

Botulinum toxin type A vs placebo

Prostatitis symptoms Subgroup: Pelvic floor muscles injection, participants age < 50 years old, basal NIH‐CPSI score < 30 · participants with chronic prostatitis/chronic pelvic pain syndrome

1 finding from 1 review

Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 29 participants
Low

Botulinum toxin type A vs placebo

Adverse events · participants with chronic prostatitis/chronic pelvic pain syndrome

Botulinum toxin A showed no clear difference in adverse events compared with placebo (low certainty).

1 finding from 1 review

Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2019 · Cochrane Headline outcomes only
RR 5 [0.25, 99.95]
2 studies · 89 participants
Low

Botulinum toxin type A vs placebo

Sexual dysfunction ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Botulinum toxin type A vs placebo

Quality of life ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Botulinum toxin type A vs placebo

Depression and anxiety ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found